Status:

TERMINATED

Evaluation of an Oral Nutritional Supplement in Older Hospitalized Patients

Lead Sponsor:

Abbott Nutrition

Conditions:

Pneumonia

Eligibility:

All Genders

55+ years

Phase:

PHASE3

Brief Summary

Study objectives are to verify the loss of lean mass during a hospital stay in a group of older patients; to evaluate the effects of consuming a high-calorie complete and balanced oral nutritional sup...

Eligibility Criteria

Inclusion

  • ≥ 55 years of age.
  • Admitted to hospital with a disease of respiratory system including acute respiratory diseases (e.g., pneumonia, acute bronchitis) or exacerbation of existing respiratory diseases.
  • Anticipated length of hospital stay of at least 3 days.
  • Ability to climb a flight of 10 stairs or walk a city block without the help of another person prior to hospitalization.
  • Able to consume foods and beverages orally.

Exclusion

  • Unstable heart failure which requires ICU admission.
  • Severe respiratory disease requiring long-term, continuous oxygen therapy.
  • Diabetes.
  • Impaired renal function.
  • Impaired liver function.
  • Cancer.
  • Hospitalized for two or more days in past 4 weeks.
  • Requires intubation or tube feeding.
  • Expected to be transferred to an advanced care unit.
  • Body mass index of ≥ 40 kg/m2.
  • Active tuberculosis.
  • Ascites or severe edema.
  • Acute Hepatitis or HIV.
  • Disorder of gastrointestinal tract.
  • Dementia;brain metastases, eating disorder, significant neurological, psychiatric disorder, other psychological condition.
  • Medication/dietary supplements/substances that could modulate metabolism or weight.
  • Partial or full artificial lower limb.
  • Allergy or intolerance to any of the ingredients in the study products.
  • Procedure using iodine-based contrast media within 7 days prior to hospitalization; or, anticipated to need procedure using iodine-based contrast media within 3 days after hospital admission.

Key Trial Info

Start Date :

October 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2012

Estimated Enrollment :

17 Patients enrolled

Trial Details

Trial ID

NCT01477723

Start Date

October 1 2011

End Date

November 1 2012

Last Update

February 15 2013

Active Locations (14)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (14 locations)

1

Horizon Research Group Inc

Mobile, Alabama, United States, 36608

2

Northwestern University

Chicago, Illinois, United States, 60611

3

Springfield Clinic

Springfield, Illinois, United States, 62703

4

Central Maine Medical Center

Lewiston, Maine, United States, 04240